Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial

• Zvi Ram,
• Chae-Yong Kim,
• Andreas F. Hottinger,
• Ahmed Idbaih,
• Garth Nicholas,
• Jay-Jiguang Zhu

Affiliations

Zvi Ram

Department of Neurosurgery, Tel Aviv Medical Center and Tel Aviv University School of Medicine, Tel Aviv, Israel

Chae-Yong Kim

Department of Neurosurgery, Seoul National University College of Medicine, Seoul, South Korea

Andreas F. Hottinger

Department of Clinical Neuroscience, CHUV Lausanne University Hospital & University of Lausanne, Lausanne, Switzerland

Ahmed Idbaih

Service de Neurologie 2-Mazarin, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière—Charles Foix, Service de Neurologie 2-Mazarin, Paris, France

Garth Nicholas

Department of Medicine, University of Ottawa, Ottawa, ON, Canada

Jay-Jiguang Zhu

Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX, United States